Jump Financial’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-37,192
Closed -$1.85M – 1763
2025
Q1
$1.85M Sell
37,192
-7,268
-16% -$460K 0.02% 608
2024
Q4
$3.11M Buy
44,460
+35,841
+416% +$2.98M 0.06% 383
2024
Q3
$904K Buy
+8,619
New +$1.01M 0.02% 838
2024
Q1
– Sell
-14,772
Closed -$1.92M – 1857
2023
Q4
$1.92M Buy
14,772
+11,936
+421% +$1.65M 0.06% 398
2023
Q3
$462K Buy
+2,836
New +$499K 0.02% 1067
2023
Q2
– Sell
-11,475
Closed -$1.53M – 1752
2023
Q1
$1.53M Buy
+11,475
New +$1.35M 0.06% 444
2022
Q4
– Sell
-4,900
Closed -$297K – 1523
2022
Q3
$297K Buy
+4,900
New +$317K 0.01% 1155

Other funds holding ACLS

Jump Financial's ACLS Position: Q2 2025 in Review

Jump Financial sold out of Axcelis (ACLS) in Q2 2025, closing a stake of 37,192 shares — an estimated $1.85M sold.

Jump Financial first reported a position in ACLS in Q3 2022 and held it in 7 quarters. The position peaked at $3.11M in Q4 2024. 329 funds tracked by Wall St. Rank hold ACLS as of Q2 2025.

  • Jump Financial reported no remaining Axcelis position as of Q2 2025 after selling out during the quarter.
  • Jump Financial sold 37,192 Axcelis shares in Q2 2025, an estimated $1.85M.
  • Jump Financial first reported a position in Axcelis in Q3 2022 and held it in 7 quarters.
  • Jump Financial's Axcelis position peaked at $3.11M in Q4 2024.
  • 329 funds tracked by Wall St. Rank held Axcelis as of Q2 2025.

Based on Jump Financial's 13F filing for Q2 2025, filed 13 Aug 2025.